Cargando…

Clinical observation and analysis of thyroid hormone levels in patients with idiopathic membranous nephropathy

We sought to investigate the effect of total triiodothyronine (TT(3)) reduction in the follow-up of patients with idiopathic membranous nephropathy (IMN). A total of 121 patients were enrolled and classified into a low TT(3) group or a normal group. Clinical indicators were compared between the grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yu, Feng, Luhuai, Li, Xian, Huang, Shanshan, Deng, Ying, Liang, Zhong-e, Xia, Ning, Yang, Zhenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035081/
https://www.ncbi.nlm.nih.gov/pubmed/32049820
http://dx.doi.org/10.1097/MD.0000000000019106
Descripción
Sumario:We sought to investigate the effect of total triiodothyronine (TT(3)) reduction in the follow-up of patients with idiopathic membranous nephropathy (IMN). A total of 121 patients were enrolled and classified into a low TT(3) group or a normal group. Clinical indicators were compared between the groups, and changes in estimated glomerular filtration rate (eGFR), albumin (ALB), thyroid-stimulating hormone, serum creatinine, total protein, total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C) during follow-up were analysed. In the analysis by TT(3) level, ALB was significantly lower in the low TT(3) group (P < .05), while TC, TG, LDL-C, fibrinogen, and renal pathological staging were significantly higher in the low TT(3) group (P < .05). Analysis of variance for repeated measurement during follow-up showed that there were no significant differences in eGFR and ALB between the groups. TC, TG, and LDL-C levels were significantly higher in the low TT(3) group (P < .05). Approximately 37% of patients with IMN showed a decrease in TT(3), which was accompanied by significantly decreased ALB level, higher pathological stage, and increased serum lipid level compared with patients having a normal TT(3) level. The management of TT(3), and appropriate intervention, may therefore help to prevent the kidney damage progress in patients with IMN.